Skip to content

Edwards Lifesciences EW Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin314.6%-3.8pp318.4%-7.4pp325.8%+8.8pp317%+14.4pp
Operating margin96.7%-8.5pp105.2%-13.9pp119.2%-9.3pp128.4%+9.6pp
Net margin189.6%-21.2pp210.8%+81.6pp129.3%+12.1pp117.2%+10.8pp
Returns
Return on equity119%-25.4pp144.4%+51.9pp92.5%-14.0pp106.5%-5.1pp
Return on invested capital65.1%-13.0pp78.1%-2.4pp80.5%-31.5pp112%-9.1pp
Efficiency
Asset turnover1.9×-0.2×2.1×0.0×-0.5×2.5×-0.2×
Liquidity
Current ratio16.9×+1.8×15.1×+2.3×12.8×-0.8×13.6×-0.7×
Leverage
Debt-to-equity0.3×-0.1×0.3×-0.1×0.4×0.0×0.5×-0.1×
Net debt / EBITDA-6×-1.6×-4.4×-3.2×-1.2×-0.4×-0.8×+0.6×
Per Share
Book value per share$70.24+23.8%$56.73+34.9%$42.07+10.6%$38.03+13.4%
Valuation
Market capitalization$182.08B-7.4%$196.6B+0.5%$195.69B-14.8%$229.62B-14.5%
Price / earnings100.3×+1.9×98.5×-38.8×137.2×-16.3×153.6×-53.6×
Price / sales31.4×-6.0×37.4×-6.9×44.3×-0.3×44.6×-9.6×
Price / book17.7×-6.4×24.1×-6.5×30.6×-8.0×38.6×-11.8×
EV / EBITDA112.1×-11.7×123.8×-9.2×133×+5.7×127.3×-41.8×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Edwards Lifesciences's profit margins?
Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.
Where do Edwards Lifesciences's ratios come from?
Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.